Drug intelligence / Profile preview

N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide is an experimental small molecule compound with the chemical formula C22H34N4O2 and a molecular weight of approximately 386.54 g/mol[1][3][6]. It belongs to the class of dipeptides, specifically containing a sequence of two amino acids, and features a prolinamide moiety. The compound has not been approved for any indication and there are no reported clinical trials beyond preclinical or biochemical testing phases[1][6]. Its mechanism of action, pharmacological activity, therapeutic target(s), and potential indications have not been described in publicly available sources as of June 2025.

Other names
N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide(2S)-N-[(4-aminocyclohexyl)methyl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamideMETHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE

Beyond the preview

Go deeper on N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call